11.77

4.27% -0.65

Third Harmonic Bio Inc (THRD)

Overview News Price History Option Chain Financials Discussions Forecast

Third Harmonic Bio Inc stock is traded at $11.77, with a volume of 23,118. It is down -4.27% in the last 24 hours and down -17.03% over the past month. Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

Previous Close:

$12.42

Open:

$12.25

24h Volume:

23,118

Relative Volume:

0.10

Market Cap:

$565.03M

Revenue:

Net Income/Loss:

$-32.74M

P/E Ratio:

-7.4882

EPS:

-1.5718

Net Cash Flow:

$-24.89M

1W Performance:

-8.04%

1M Performance:

-17.03%

6M Performance:

-12.38%

1Y Performance:

+28.68%

1-Day Range:

$11.58

$12.42

1-Week Range:

$11.58

$13.53

52-Week Range:

$8.075

$16.94

Third Harmonic Bio Inc Stock (THRD) Company Profile

Name

Third Harmonic Bio Inc

Sector

Healthcare (1180)

Industry

Biotechnology (683)

Phone

(209) 727-2457

Address

1700 MONTGOMERY STREET, SAN FRANCISCO

Employee

Twitter

Next Earnings Date

Latest SEC Filings

THRD's Discussions on Twitter

Compare THRD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
THRD Third Harmonic Bio Inc	11.99	565.03M	0	-32.74M	-24.89M	-0.82
VRTX Vertex Pharmaceuticals Inc	461.74	119.71B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	754.12	82.77B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	620.93	37.02B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	251.31	32.26B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.73	28.24B	3.30B	-501.07M	1.03B	-2.1146

Third Harmonic Bio Inc Stock (THRD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-09-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jun-18-24	Initiated	Stifel	Buy
Jun-07-24	Initiated	Raymond James	Outperform
Dec-16-22	Downgrade	Jefferies	Buy → Hold
Dec-15-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Oct-10-22	Initiated	Cowen	Outperform
Oct-10-22	Initiated	Jefferies	Buy
Oct-10-22	Initiated	Morgan Stanley	Overweight

View All

Third Harmonic Bio Inc Stock (THRD) Latest News

Nov 26, 2024

How the (THRD) price action is used to our Advantage - Stock Traders Daily

Nov 26, 2024

Nov 25, 2024

Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference - Marketscreener.com

Nov 25, 2024

Third Harmonic Bio to Present at Evercore HealthCONx Conference in December | THRD Stock News - StockTitan

Nov 25, 2024

Nov 20, 2024

Wall Street Analysts Believe Third Harmonic Bio, Inc. (THRD) Could Rally 26.67%: Here's is How to Trade - MSN

Nov 20, 2024

Nov 15, 2024

(THRD) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 15, 2024

RA Capital Management Reduces Stake in Third Harmonic Bio Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Significant Stake Increase by T. Rowe Price in Third Harmonic Bi - GuruFocus.com

Nov 14, 2024

Nov 11, 2024

Vertiv Rises 13% in a Month: Time for Investors to Buy the Stock? - MSN

Nov 11, 2024

Shiba Inu (SHIB) Price Rises 53% but Hits Rejection at Key Ascending Resistance Level - MSN

Nov 11, 2024

Nov 08, 2024

Third Harmonic Bio Reports Q3 2024 Financial Results - TipRanks

Nov 08, 2024

Nov 07, 2024